Expanded Access Policy

Fortvita Biologics (USA), Inc. is a clinical-stage pharmaceutical company focused on the development of investigational products that have not been approved by the U.S. Food and Drug Administration (FDA).

At this time, Fortvita is not offering expanded access to its investigational products outside of clinical trials. For questions or more information, please contact Fortvita Biologics (USA) at ClinicalDevelopment@fortvitabio.com.